Patent directory · USPTO A61K / A61P
Patents matching “modified”
433 pharma patents match "modified" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 433 pharmaceutical patents matching "modified" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10982203
Modified factor IX polypeptides and uses thereof
granted -
US 10954501
Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use
granted -
US 10954498
Modified cascade ribonucleoproteins and uses thereof
granted -
US 10941402
Chemically modified single-stranded RNA-editing oligonucleotides
granted -
US 10913957
Genetically modified MSC and therapeutic methods
granted -
US 10905709
Modified antisense oligomers for exon inclusion in spinal muscular atrophy
granted -
US 10881086
Genetically modified mouse whose genome comprises a humanized CD274 gene
granted -
US 10875885
β-d-2′-deoxy-2′-α-fluoro-2′-β-c-substituted-2-modified-n6-substituted purine nucleotides for HCV treatment
granted -
US 10870673
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
granted -
US 10870672
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
granted -
US 10864266
Modified lipopolysaccharide glycoform and method of use
granted -
US 10858633
Method for producing foot-and-mouth disease virus (FMDV) viral proteins utilizing a modified FMDV 3C protease
granted -
US 10844098
Method for preparing bacterial polysaccharide-modified recombinant fusion protein and use of the protein
granted -
US 10842743
Modified hyaluronic acid hydrogels and proteins for the time-controlled release of biologic agents
granted -
US 10835593
Modified anthrax toxin protective antigen
granted -
US 10815266
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
granted -
US 10808230
Selection methods for genetically-modified T cells
granted -
US 10800833
Co-stimulatory domains for use in genetically-modified cells
granted -
US 10785968
Genetically modified non-human animals and methods of use thereof
granted -
US 10781435
Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use
granted -
US 10760078
Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
granted -
US 10730837
Modified amino acids
granted -
US 10722459
Methods for producing carboxylate ligand modified ferric iron hydroxide colloids and related compositions and uses
granted -
US 10717720
Modified compound of andrographolide
granted